Lifecore Signs Manufacturing Deal for Injectable Ophthalmic Product

Lifecore Biomedical, Inc. announced a new manufacturing services agreement with a leading provider of ophthalmic disease management solutions. The agreement entails process development and technical transfer services, preparing for potential commercial manufacturing of an injectable ophthalmic product following regulatory approval. This program, which involves reformulating a commercially approved product into pre-filled syringes, marks the sixth addition to Lifecore's late-stage pipeline in seven months, strengthening its growth strategy.